0001209191-12-042410.txt : 20120817 0001209191-12-042410.hdr.sgml : 20120817 20120817141925 ACCESSION NUMBER: 0001209191-12-042410 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120815 FILED AS OF DATE: 20120817 DATE AS OF CHANGE: 20120817 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 121042282 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2012-08-15 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 EVP, Global R&D, CSO Common Stock 2012-08-15 4 M 0 6500 16.32 A 138816 D Common Stock 2012-08-15 4 S 0 2400 53.84 D 136416 D Common Stock 2012-08-15 4 S 0 4100 54.30 D 132316 D Common Stock 4647 I 401(k) Common Stock 15920 I Common Stock held in trust. Employee Stock Option Grant (right to buy) 16.32 2012-08-15 4 M 0 6500 0.00 D 2013-07-14 Common Stock 6500 22800 D Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $53.84 (range $53.37 to $53.99). Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $54.30 (range $54.00 to $54.69). Common stock held in grantor retained annuity trusts. Fully vested. Valerie L. Andrews, Attorney-In-Fact 2012-08-17